ArticlePublisher preview available
To read the full-text of this research, you can request a copy directly from the authors.

Abstract and Figures

Purpose of Review To review the etiopathology of the different grades of accreta placentation and evaluate its impact on management strategies and outcomes. Recent Findings Accreta placentation is essentially the consequence of prior uterine surgery, mainly multiple cesarean deliveries which often result in large scar defects with absence of re-epithelialization by the endometrium. Invasive placentation is associated with high maternal morbidity and if undiagnosed before delivery can lead to massive obstetric hemorrhage leading to maternal death. The clinical symptoms of an adherent placenta accreta are very similar to those of placental retention and the inclusion of both conditions in cohort studies has artificially increased the prevalence of placenta accreta spectrum. Similarly, the damage to the myometrial tissue of the lower uterine segment resulting from multiple cesarean incisions often leads a large area of dehiscence which can be mistaken for placenta percreta. Summary The degree of success and main outcomes of the different therapeutic strategies in women presenting with placenta accreta spectrum are related to the grade of placental attachment abnormality. Systematic and prospectively collected clinical data including intended and actual mode of management, complications, and long-term follow-up data are essential to the development of tailored management strategies for the increasing number of women presenting with accreta placentation. The quality of the data reported in the medical literature, and in particular on the accurate diagnosis of the different grades of PAS at birth, is pivotal to improve the management and outcome of this complex obstetric complication.
This content is subject to copyright. Terms and conditions apply.
ABERRANT PLACENTATION: CONTEMPORARY MANAGEMENT OF PLACENTA ACCRETA (E
JAUNIAUX, SECTION EDITOR)
From Etiopathology to Management of Accreta Placentation
Eric Jauniaux
1
&Graham J. Burton
2
Published online: 20 May 2019
#Springer Science+Business Media, LLC, part of Springer Nature 2019
Abstract
Purpose of Review To review the etiopathology of the different grades of accreta placentation and evaluate its impact on
management strategies and outcomes.
Recent Findings Accreta placentation is essentially the consequence of prior uterine surgery, mainly multiple cesarean deliveries
which often result in large scar defects with absence of re-epithelialization by the endometrium. Invasive placentation is asso-
ciated with high maternal morbidity and if undiagnosed before delivery can lead to massive obstetric hemorrhage leading to
maternal death. The clinical symptoms of an adherent placenta accreta are very similar to those of placental retention and the
inclusion of both conditions in cohort studies has artificially increased the prevalence of placenta accreta spectrum. Similarly, the
damage to the myometrial tissue of the lower uterine segmentresulting from multiple cesarean incisions often leads a large area of
dehiscence which can be mistaken for placenta percreta.
Summary The degree of success and main outcomes of the different therapeutic strategies in women presenting with placenta
accreta spectrum are related tothe grade of placental attachment abnormality. Systematic and prospectively collected clinical data
including intended and actual mode of management, complications, and long-term follow-up data are essential to the develop-
ment of tailored management strategies for the increasing number of women presenting with accreta placentation. The quality of
the data reported in the medical literature, and in particular on the accurate diagnosis of the different grades of PAS at birth, is
pivotal to improve the management and outcome of this complex obstetric complication.
Keywords Placenta accreta .Placenta increta .Placenta percreta .Diagnosis .Management
Introduction
Placenta accreta spectrum(PAS) is a relatively new disorder of
human placentation with only a few publications published in
the modern medical literature during the first half of the twen-
tieth century [1]. Obstetrician Frederick C. Irving and pathol-
ogist Arthur T. Hertig from the Boston Lying-In Hospital were
the first to report in 1937 a cohort of 18 cases of placenta
accreta veraor adherenta[2]. They described their cases
clinically as the abnormal adherence of the afterbirth in
whole or in parts to the underlying uterine wall[2].
Microscopically, they found that the common histological
sign between their cases was the complete or partial absence
of the decidua basalis.
Three decades later, Luke et al. were the first to show that
the degree of villous adhesion or invasion is rarely uniform
across the placental bed, and that many cases of PAS present
with both adherent and invasive areas [3]. They described
accreta placentation as a spectrum of abnormally adherent
and invasive placentation disorders, and highlighted the need
to differentiate between abnormally adherent and abnormally
invasive placentas and report on the lateral extension of the
accreta area. PAS is now graded according to the depth of
This article is part of the Topical Collection on Aberrant Placentation:
Contemporary Management of Placenta Accreta
*Eric Jauniaux
e.jauniaux@ucl.ac.uk
Graham J. Burton
Gjb2@cam.ac.uk
1
EGA Institute for Womens Health, University College London,
86-96 Chenies Mews, London WC1E 6HX, UK
2
Department of Physiology, The Centre for Trophoblast Research,
Development and Neuroscience, University of Cambridge,
Cambridge, UK
Current Obstetrics and Gynecology Reports (2019) 8:5563
https://doi.org/10.1007/s13669-019-0261-y
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Placenta accreta spectrum is impacting maternal health outcomes globally and its prevalence is likely to increase. Maternal outcomes depend on identification of the condition before or during delivery and, in particular, on the differential diagnosis between its adherent and invasive forms. However, accurate estimation of its prevalence and outcome is currently problematic because of the varying use of clinical criteria to define it at birth and the lack of detailed pathologic examination in most series. Adherence to this new International Federation of Gynecology and Obstetrics (FIGO) classification should improve future systematic reviews and meta‐analyses and provide more accurate epidemiologic data which are essential to develop new management strategies.
Article
Full-text available
During placentation invasive extravillous trophoblasts (EVTs) migrate into the maternal uterus and modify its vessels. In particular, remodeling of the spiral arteries by EVTs is critical for adapting blood flow and nutrient transport to the developing fetus. Failures in this process have been noticed in different pregnancy complications such as preeclampsia, intrauterine growth restriction, stillbirth, or recurrent abortion. Upon invasion into the decidua, the endometrium of pregnancy, EVTs encounter different maternal cell types such as decidual macrophages, uterine NK (uNK) cells and stromal cells expressing a plethora of growth factors and cytokines. Here, we will summarize development of the EVT lineage, a process occurring independently of the uterine environment, and formation of its different subtypes. Further, we will discuss interactions of EVTs with arteries, veins and lymphatics and illustrate how the decidua and its different immune cells regulate EVT differentiation, invasion and survival. The present literature suggests that the decidual environment and its soluble factors critically modulate EVT function and reproductive success.
Article
Full-text available
A caesarean section (CS) can be a life-saving intervention when medically indicated, but this procedure can also lead to short-term and long-term health effects for women and children. Given the increasing use of CS, particularly without medical indication, an increased understanding of its health effects on women and children has become crucial, which we discuss in this Series paper. The prevalence of maternal mortality and maternal morbidity is higher after CS than after vaginal birth. CS is associated with an increased risk of uterine rupture, abnormal placentation, ectopic pregnancy, stillbirth, and preterm birth, and these risks increase in a dose-response manner. There is emerging evidence that babies born by CS have different hormonal, physical, bacterial, and medical exposures, and that these exposures can subtly alter neonatal physiology. Short-term risks of CS include altered immune development, an increased likelihood of allergy, atopy, and asthma, and reduced intestinal gut microbiome diversity. The persistence of these risks into later life is less well investigated, although an association between CS use and greater incidence of late childhood obesity and asthma are frequently reported. There are few studies that focus on the effects of CS on cognitive and educational outcomes. Understanding potential mechanisms that link CS with childhood outcomes, such as the role of the developing neonatal microbiome, has potential to inform novel strategies and research for optimising CS use and promote optimal physiological processes and development.
Article
Objective data: The objective of this study was to evaluate the prevalence of placenta accreta spectrum in general population studies and the main maternal outcomes at delivery. Study: We searched PubMed, Google Scholar, clinicalTrials.gov, and MEDLINE between 1982 and 2018. Articles that provided data on the number of cases of placenta accreta spectrum per pregnancies, births, or deliveries in a defined population were used. Study appraisal and synthesis methods: Study characteristics were evaluated by 2 independent reviewers who used a predesigned protocol. Primary outcomes were the prevalence of placenta accreta spectrum and clinical diagnostic data at birth; the pathologic criteria were used to confirm the diagnosis. Secondary outcomes included cases that required transfusion, incidence of peripartum hysterectomy, and maternal mortality rates. Heterogeneity between studies was analyzed with the Cochran's Q-test and the I2 statistics. Results: Of the 98 full-text studies that were identified, 29 articles met the defined criteria and included 22 retrospective and 7 prospective studies comprising 7001 cases of placenta accreta spectrum of 5,719,992 births. Prevalence rates ranged from 0.01-1.1% with an overall pooled prevalence of 0.17% (95% confidence interval, 0.14-0.19). Only 10 studies provided detailed histopathologic data. The pool prevalence for the adherent vs the invasive grades was 0.5 (95% confidence interval, 0.3-0.36) and 0.3 (95% confidence interval, 0.2-0.4) per 1000 births, respectively. The pooled incidence for peripartum hysterectomy was 52.2% (95% confidence interval, 38.3-66.4; I2=99.8%) and 46.9% (95 % confidence interval, 34-59.9; I2=98.8%) for hemorrhage that required transfusion. The pooled estimate of maternal death was 0.05% (95% confidence interval, 0.06-0.69; I2=73%). We found large amounts of heterogeneity between studies for all parameters and further quantification was limited because of methodologic inconsistencies between studies with regards to clinical criteria that were used for the diagnosis of the condition at birth and the histopathologic confirmation of the diagnosis and differential diagnosis between adherent and invasive accreta placentation. Conclusion: This meta-analysis indicated wide variation between studies for the prevalence rate of placenta accreta spectrum and for the different grades of accreta placentation that highlighted the need for consistency in definitions that are used to describe placenta accreta spectrum at birth and in the reporting of this increasing common obstetric complication.
Article
Regenerating cardiac muscle lost during a heart attack is a topic of broad interest and enormous potential impact. One promising approach is to regenerate or re-engineer new myocardium in situ, at the site of damage, by injecting cells, growth factors, and other materials, or by reprogramming aspects of the normal wound healing process. A wide variety of strategies have been explored, from promoting angiogenesis to injection of a variety of different progenitor cell types, to re-engineering resident cells to produce key growth factors or even transdifferentiate into myocytes. Despite substantial progress and continued promise, clinical impact of this work has fallen short of expectations. One contributing factor may be that many efforts focus primarily on generating cardiomyocytes, with less attention to re-engineering the extracellular matrix (ECM). Yet the role of the ECM is particularly crucial to consider following myocardial infarction, which leads to rapid formation of a collagen-rich scar. This review combines a brief summary of current efforts to regenerate cardiomyocytes with what is currently known about the structure and mechanics of post-infarction scar, with the goal of identifying principles that can guide efforts to produce new myocytes embedded in an extracellular environment that facilitates their differentiation, maintenance, and function.
Article
Purpose: Management of patients with placenta accreta spectrum (PAS) varies widely, and scarce data exist concerning its management. The current study compared two different surgical approaches in the management of PAS: the B-lynch approach (Group A) compared to the endovascular balloon catheters (Group B) Methods: A retrospective cohort study, in two tertiary university-affiliated hospitals between the years 2004 and 2015. Elective cesarean section was planned at 35–37 weeks of gestation. One center utilized the B-lynch approach and the second utilized the endovascular balloon catheter approach. Results: The cesarean hysterectomy rate was significantly higher in the Group A approach compared to Group B (36.1 versus 29.2%, p = 0.00). The number of packed cells units administered during and postoperatively were higher in the Group A versus to Group B (p = 0.006 and 0.043 respectively). Overall, surgery length and hospitalization duration were shorter in patients who underwent cesarean hysterectomy compared with those who underwent uterine preservation (B-lynch or endovascular balloon catheters) (p = 0.000 and p = 0.004, respectively). Conclusions: The endovascular balloon technique seems a better option for uterine preservation due to less blood loss and higher postoperative hemoglobin level. Nevertheless for those women who have completed their family planning, cesarean hysterectomy with the placenta left in situ is the safer and more suitable option.
Article
Background: Cesarean delivery rates in Brazil are among the highest in the world. User preference is often mentioned as an important factor driving this. Objectives: To identify, appraise, and synthesize the results of studies into delivery preferences in Brazil. Search strategy: MEDLINE, LILACS, and PsycINFO databases were searched, without language restrictions, using "delivery" and "preference" from inception to November 4, 2017. Selection criteria: Cross-sectional or cohort studies with quantitative data on delivery preferences of lay persons in Brazil. Data collection and analysis: Two reviewers performed study selection, quality assessment, and data extraction. A meta-analysis of proportions with a preference for cesarean delivery was performed, including subgroups analyses. Main results: There were 28 studies with 31 071 participants included. The overall prevalence of preference for cesarean delivery was 27.2% (95% confidence interval [CI] 26.7%-27.7%; 28 studies, n=31 071). Cesarean delivery preference was higher among multiparas with previous cesarean deliveries (58.0%, 95% CI 56.6%-59.3%; nine studies, n=5542) than among multiparas without prior cesarean deliveries (17.3%, 95% CI 16.4%-18.2%; eight studies, n=7903), and among women with private health insurance (44.3%, 95% CI 43.0%-45.6%; nine studies, n=6048) than among those who depended on the public healthcare system (22.7%, 95% CI 22.2%-23.3%; 20 studies, n=24 314). Conclusions: Overall, most lay persons in Brazil did not prefer to deliver by cesarean. This article is protected by copyright. All rights reserved.